Skip to content
2000
Volume 2, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Globally, COVID-19 is a viral disease that has become a public health challenge in 2020. COVID-19 is caused by a novel coronavirus, SARS-CoV 2, that was first discovered in the Hubei province of China and it commonly manifests as a respiratory illness but also with symptoms ranging from mild myalgia to severe pneumonia. As our primitive understanding of this novel virus has evolved, COVID-19 has been shown to present in atypical non-pulmonary clinical manifestations, such as diarrhea, acute kidney injury, hepatic and cardiovascular abnormalities, blood coagulation and stroke along with loss of some special senses. We consolidated the publicly available information to precisely summarize the knowledge about the significant non-respiratory clinical manifestations of COVID-19.

© 2021 Bentham Science Publishers
© 2021 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0250688203666210111152702
2021-01-11
2025-11-02

  • From This Site

    /content/journals/nemj/10.2174/0250688203666210111152702
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/2/1/NEMJ-2-1-04.html?itemId=/content/journals/nemj/10.2174/0250688203666210111152702&mimeType=html&fmt=ahah

References

  1. HuangC. WangY. LiX. RenL. ZhaoJ. HuY. ZhangL. FanG. XuJ. GuX. ChengZ. YuT. XiaJ. WeiY. WuW. XieX. YinW. LiH. LiuM. XiaoY. GaoH. GuoL. XieJ. WangG. JiangR. GaoZ. JinQ. WangJ. CaoB. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet20203951022349750610.1016/S0140‑6736(20)30183‑531986264
     [Google Scholar]
  2. GuJ. GongE. ZhangB. ZhengJ. GaoZ. ZhongY. ZouW. ZhanJ. WangS. XieZ. ZhuangH. WuB. ZhongH. ShaoH. FangW. GaoD. PeiF. LiX. HeZ. XuD. ShiX. AndersonV.M. LeongA.S. Multiple organ infection and the pathogenesis of SARS.J. Exp. Med.2005202341542410.1084/jem.2005082816043521
     [Google Scholar]
  3. HolshueM.L. DeBoltC. LindquistS. LofyK.H. WiesmanJ. BruceH. SpittersC. EricsonK. WilkersonS. TuralA. DiazG. CohnA. FoxL. PatelA. GerberS.I. KimL. TongS. LuX. LindstromS. PallanschM.A. WeldonW.C. BiggsH.M. UyekiT.M. PillaiS.K. Washington State 2019-nCoV Case Investigation Team First Case of 2019 Novel Coronavirus in the United States.N. Engl. J. Med.20203821092993610.1056/NEJMoa200119132004427
     [Google Scholar]
  4. ZhouP. YangX.L. WangX.G. HuB. ZhangL. ZhangW. SiH.R. ZhuY. LiB. HuangC.L. ChenH.D. ChenJ. LuoY. GuoH. JiangR.D. LiuM.Q. ChenY. ShenX.R. WangX. ZhengX.S. ZhaoK. ChenQ.J. DengF. LiuL.L. YanB. ZhanF.X. WangY.Y. XiaoG.F. ShiZ.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature2020579779827027310.1038/s41586‑020‑2012‑732015507
     [Google Scholar]
  5. HarmerD. GilbertM. BormanR. ClarkK.L. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme.FEBS Lett.20025321-210711010.1016/S0014‑5793(02)03640‑212459472
     [Google Scholar]
  6. YanR. ZhangY. LiY. XiaL. GuoY. ZhouQ. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.Science202036764851444144810.1126/science.abb276232132184
     [Google Scholar]
  7. XiaoF. TangM. ZhengX. LiuY. LiX. ShanH. Evidence for gastrointestinal infection of SARS-CoV-2.Gastroenterology202015861831183310.1053/j.gastro.2020.02.05532142773
     [Google Scholar]
  8. GuJ. HanB. WangJ. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission.Gastroenterology202015861518151910.1053/j.gastro.2020.02.05432142785
     [Google Scholar]
  9. ChenL. LouJ. BaiY. WangM. COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests.Am. J. Gastroenterol.2020115579010.14309/ajg.000000000000061032205644
     [Google Scholar]
  10. PanL. MuM. YangP. SunY. WangR. YanJ. LiP. HuB. WangJ. HuC. JinY. NiuX. PingR. DuY. LiT. XuG. HuQ. TuL. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study.Am. J. Gastroenterol.2020115576677310.14309/ajg.000000000000062032287140
     [Google Scholar]
  11. MaoR. QiuY. HeJ-S. TanJ.Y. LiX.H. LiangJ. ShenJ. ZhuL.R. ChenY. IacucciM. NgS.C. GhoshS. ChenM.H. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.Lancet Gastroenterol. Hepatol.20205766767810.1016/S2468‑1253(20)30126‑632405603
     [Google Scholar]
  12. WuY. GuoC. TangL. HongZ. ZhouJ. DongX. YinH. XiaoQ. TangY. QuX. KuangL. FangX. MishraN. LuJ. ShanH. JiangG. HuangX. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.Lancet Gastroenterol. Hepatol.20205543443510.1016/S2468‑1253(20)30083‑232199469
     [Google Scholar]
  13. JamieS. Hirsch, Jia H. Ng, Daniel W. Ross, Purva Sharma, Hitesh H. Shah, Richard L. Barnett, Azzour D. Hazzan, Steven Fishbane, Kenar D. Jhaveri; on behalf of the Northwell COVID-19 Research Consortium and the Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19.Kidney Int.202010.1016/j.kint.2020.05.006
     [Google Scholar]
  14. WangH.E. MuntnerP. ChertowG.M. WarnockD.G. Acute kidney injury and mortality in hospitalized patients.Am. J. Nephrol.201235434935510.1159/00033748722473149
     [Google Scholar]
  15. ChengY. LuoR. WangK. ZhangM. WangZ. DongL. LiJ. YaoY. GeS. XuG. Kidney disease is associated with in-hospital death of patients with COVID-19.Kidney Int.202097582983810.1016/j.kint.2020.03.00532247631
     [Google Scholar]
  16. ChenN. ZhouM. DongX. QuJ. GongF. HanY. QiuY. WangJ. LiuY. WeiY. XiaJ. YuT. ZhangX. ZhangL. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet20203951022350751310.1016/S0140‑6736(20)30211‑732007143
     [Google Scholar]
  17. CaiQ. HuangD. YuH. ZhuZ. XiaZ. SuY. LiZ. ZhouG. GouJ. QuJ. SunY. LiuY. HeQ. ChenJ. LiuL. XuL. COVID-19: Abnormal liver function tests.J. Hepatol.202073356657410.1016/j.jhep.2020.04.00632298767
     [Google Scholar]
  18. GuanW.J. NiZ.Y. HuY. LiangW.H. OuC.Q. HeJ.X. LiuL. ShanH. LeiC.L. HuiD.S.C. DuB. LiL.J. ZengG. YuenK-Y. ChenR.C. TangC.L. WangT. ChenP.Y. XiangJ. LiS.Y. WangJ.L. LiangZ.J. PengY.X. WeiL. LiuY. HuY.H. PengP. WangJ.M. LiuJ.Y. ChenZ. LiG. ZhengZ.J. QiuS.Q. LuoJ. YeC.J. ZhuS.Y. ZhongN.S. China Medical Treatment Expert Group for Covid-19 Clinical Characteristics of Coronavirus Disease 2019 in China.N. Engl. J. Med.2020382181708172010.1056/NEJMoa200203232109013
     [Google Scholar]
  19. LiJ. FanJ-G. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.J. Clin. Transl. Hepatol.202081131710.14218/JCTH.2020.0001932274341
     [Google Scholar]
  20. ACC Clinical Bulletin Covid-19 Clinical Guidance For the CV Care Team.https://www.acc.org//~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/2020/02/S20028-ACC-Clinical-Bulletin-Coronavirus.pdf
     [Google Scholar]
  21. LongB. BradyW.J. KoyfmanA. GottliebM. Cardiovascular complications in COVID-19.Am. J. Emerg. Med.20203871504150710.1016/j.ajem.2020.04.04832317203
     [Google Scholar]
  22. ChanJ.W. NgC.K. ChanY.H. MokT.Y. LeeS. ChuS.Y. LawW.L. LeeM.P. LiP.C. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).Thorax200358868668910.1136/thorax.58.8.68612885985
     [Google Scholar]
  23. BoothC.M. MatukasL.M. TomlinsonG.A. RachlisA.R. RoseD.B. DwoshH.A. WalmsleyS.L. MazzulliT. AvendanoM. DerkachP. EphtimiosI.E. KitaiI. MederskiB.D. ShadowitzS.B. GoldW.L. HawryluckL.A. ReaE. ChenkinJ.S. CesconD.W. PoutanenS.M. DetskyA.S. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.JAMA2003289212801280910.1001/jama.289.21.JOC3088512734147
     [Google Scholar]
  24. EketundeA.O. MellacheruvuS.P. OreoluwaP. A review of postmortem findings in patients with COVID-19.Cureus2020127e943810.7759/cureus.943832864262
     [Google Scholar]
  25. XuZ. ShiL. WangY. ZhangJ. HuangL. ZhangC. LiuS. ZhaoP. LiuH. ZhuL. TaiY. BaiC. GaoT. SongJ. XiaP. DongJ. ZhaoJ. WangF.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome.Lancet Respir. Med.20208442042210.1016/S2213‑2600(20)30076‑X32085846
     [Google Scholar]
  26. MadjidM. Safavi-NaeiniP. SolomonS.D. VardenyO. Potential effects of coronaviruses on the cardiovascular system: A review.JAMA Cardiol.20205783184010.1001/jamacardio.2020.128632219363
     [Google Scholar]
  27. BryceClare Pathophysiology of SARS-CoV-2: Targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response.The Mount Sinai COVID-19 autopsy experience2020
     [Google Scholar]
  28. LiY. LiM. WangM. ZhouY. ChangJ. XianY. WangD. MaoL. JinH. HuB. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.Stroke Vasc. Neurol.20205327928410.1136/svn‑2020‑00043132616524
     [Google Scholar]
  29. ZhouF. YuT. DuR. FanG. LiuY. LiuZ. XiangJ. WangY. SongB. GuX. GuanL. WeiY. LiH. WuX. XuJ. TuS. ZhangY. ChenH. CaoB. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet2020395102291054106210.1016/S0140‑6736(20)30566‑332171076
     [Google Scholar]
  30. OxleyT.J. MoccoJ. MajidiS. KellnerC.P. ShoirahH. SinghI.P. De LeacyR.A. ShigematsuT. LadnerT.R. YaegerK.A. SkliutM. WeinbergerJ. DangayachN.S. BedersonJ.B. TuhrimS. FifiJ.T. Large-vessel stroke as a presenting feature of Covid-19 in the young.N. Engl. J. Med.202038220e6010.1056/NEJMc200978732343504
     [Google Scholar]
  31. KlokF KruipM van der MeerN ArbuosM GommersD KantK Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thromb Res2020203012030121
     [Google Scholar]
  32. MaoL WangM ChenS HeQ ChangJ HongC Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, ChinaA retrospective case series study.
     [Google Scholar]
  33. XieY. WangX. YangP. ZhangS. COVID-19 complicated by acute pulmonary embolism. Radiology.Cardiothoracic Imaging202022e20006710.1148/ryct.2020200067
     [Google Scholar]
  34. DanziG.B. LoffiM. GaleazziG. GherbesiE. Acute pulmonary embolism and COVID-19 pneumonia: a random association?Eur. Heart J.20204119185810.1093/eurheartj/ehaa25432227120
     [Google Scholar]
  35. TangN. LiD. WangX. SunZ. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.J. Thromb. Haemost.202018484484710.1111/jth.1476832073213
     [Google Scholar]
  36. TangN. BaiH. ChenX. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J. Thromb. Haemost.2020Mar2710.1111/jth.14817
     [Google Scholar]
  37. BaigA.M. KhaleeqA. AliU. SyedaH. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms.ACS Chem. Neurosci.202011799599810.1021/acschemneuro.0c0012232167747
     [Google Scholar]
  38. RiphagenS. GomezX. Gonzalez-MartinezC. WilkinsonN. TheocharisP. Hyperinflammatory shock in children during COVID-19 pandemic.Lancet2020395102371607160810.1016/S0140‑6736(20)31094‑132386565
     [Google Scholar]
  39. WhittakerE. BamfordA. KennyJ. KaforouM. JonesC.E. ShahP. RamnarayanP. FraisseA. MillerO. DaviesP. KuceraF. BrierleyJ. McDougallM. CarterM. TremouletA. ShimizuC. HerbergJ. BurnsJ.C. LyallH. LevinM. PIMS-TS Study Group and EUCLIDS and PERFORM Consortia Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.JAMA2020324325926910.1001/jama.2020.1036932511692
     [Google Scholar]
  40. KontzialisM. SoaresB.P. HuismanT.A.G.M. Lesions in the splenium of the corpus callosum on MRI in children: a review.J. Neuroimaging201727654956110.1111/jon.1245528654166
     [Google Scholar]
  41. Rachel KayeC.W. David Chang, Ken Kazahaya, Jean Brereton, James C. Denneny. COVID-19 Anosmia Reporting Tool: Initial Findings.Otolaryngol. Head Neck Surg.202013
     [Google Scholar]
  42. KimY . . (Exclusive) Daegu 15% of 3191 confirmed patients lost their sense of smell or taste. Article in KoreanJungang Daily
     [Google Scholar]
  43. WuP. DuanF. LuoC. LiuQ. QuX. LiangL. WuK. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in hubei province, China.JAMA Ophthalmol.2020138557557810.1001/jamaophthalmol.2020.129132232433
     [Google Scholar]
  44. LiuZ. SunC.B. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.J. Med. Virol.20209291410141210.1002/jmv.2585932275082
     [Google Scholar]
/content/journals/nemj/10.2174/0250688203666210111152702
Loading

  • Article Type:     Review Article
Keyword(s): Atypical symptoms; COVID-19; Non-respiratory; Novel virus; Pathophysiology; Viral disease

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test